Amanda Kindel in Hattiesburg, Mississippi

Home Mississippi Hattiesburg

Amanda Kindel has Nurse Practitioner as her primary medical specialty. Their primary office is: 5003 Hardy St Tower B in Hattiesburg, Mississippi. There is an additional office location, for a total of two, for Amanda Kindel that can be viewed further down.

They're a part of the: David B Roy Do Pa medical group which has around 10 members. You can call their office at 601-336-5626 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, her university is not listed and graduated in 2020 (around 4 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Amanda Patterson Kindel Office Phone and Directions

Amanda Kindel
David B Roy Do Pa
5003 Hardy St Tower B
Hattiesburg, Mississippi 39402
601-336-5626

Patient Ratings
Please rate your experience with Amanda Kindel below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 601-336-5626

Enter a starting address:

Healthcare Info for Amanda Kindel

Medical School: Sorry, her university is not listed
Graduation Year: 2020
The Primary Medical Specialty for Amanda Kindel is listed as: Nurse Practitioner
Approximate Years of Experience: 4
PAC (PECOS ID)#: 1557753589
NPI #: 1265003792
NPI Created On: 07/06/2021
NPI Last Updated Listed as: 09/18/2021
Primary Taxonomy Code: 363LF0000X
License Number:
904727
Listed Gender: Female

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest:

Record ID:: 843488921

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Immunology

Name of Drug #1: DUPIXENT

Open Associated Drug #1: 0024-5914-01